{"news_desk": "Business", "print_page": null, "section_name": "Business Day", "subsection_name": "DealBook", "byline": {"original": "By LESLIE PICKER", "person": [{"rank": 1, "role": "reported", "firstname": "Leslie", "organization": "", "lastname": "PICKER"}]}, "abstract": null, "type_of_material": "News", "word_count": "379", "lead_paragraph": "The two biotech companies\u2019 initial public offerings are testing the waters after a recent sell-off in biotech.", "pub_date": "2016-02-04T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "Editas Medicine and BeiGene Gain in Market Debuts"}, "snippet": "The two biotech companies\u2019 initial public offerings are testing the waters after a recent sell-off in biotech.", "multimedia": [], "web_url": "http://www.nytimes.com/2016/02/04/business/dealbook/editas-medicine-and-beigene-gain-in-market-debuts.html", "keywords": [{"rank": "1", "is_major": "N", "value": "Initial Public Offerings", "name": "subject"}, {"rank": "2", "is_major": "N", "value": "Beigene Ltd.", "name": "organizations"}, {"rank": "3", "is_major": "N", "value": "Editas Medicine Inc", "name": "organizations"}, {"rank": "4", "is_major": "N", "value": "Genetics and Heredity", "name": "subject"}, {"rank": "5", "is_major": "N", "value": "Biotechnology and Bioengineering", "name": "subject"}], "blog": [], "_id": "56b23fb338f0d82036f0a7aa", "source": "The New York Times"}